People who had used cannabis before were less affected by THC than those who had never tried it

In a THC challenge study, people with even modest prior cannabis exposure showed blunted psychotic symptoms and behavioral impairment compared to cannabis-naive individuals, who experienced more pronounced effects.

Colizzi, Marco et al.·Experimental and clinical psychopharmacology·2018·Moderate EvidenceRandomized Controlled Trial
RTHC-01625Randomized Controlled TrialModerate Evidence2018RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Randomized Controlled Trial
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Twenty-four healthy men participated in a double-blind THC challenge study, divided into 12 never-users (fewer than 5 lifetime joints) and 12 abstinent modest users (about 25 lifetime joints). Both groups received THC and placebo on separate occasions.

The never-users experienced significantly more THC-induced psychotic symptoms and behavioral impairment on attention tasks than the modest users. Under THC, never-users shifted to recruiting different brain areas to perform tasks, suggesting the drug fundamentally disrupted their normal brain processing patterns.

Modest cannabis users showed a different baseline pattern even under placebo: they processed attentional and emotional stimuli using different brain areas compared to never-users, suggesting lasting residual effects from their modest exposure history. However, when challenged with THC, their responses were more blunted and less disrupted.

The severity of psychotic symptoms and cognitive impairment from THC correlated with the degree of neurophysiological disruption, but only in never-users. Modest users showed an exposure-dependent tolerance that protected them from the worst acute effects.

Key Numbers

24 healthy men: 12 non-users (<5 lifetime joints), 12 modest users (24.5 lifetime joints). THC-induced psychotic symptoms more pronounced in non-users (p < 0.04). Behavioral impairment greater in non-users. Non-users showed more neurophysiological disruption. Modest users showed residual brain function changes under placebo.

How They Did This

Double-blind, randomized, placebo-controlled, repeated-measures, within-subject crossover study with fMRI. Twenty-four healthy men received THC challenge: 12 non-users (<5 lifetime joints) and 12 abstinent modest users (24.5 lifetime joints). Attentional salience and emotional processing were assessed behaviorally and neurophysiologically.

Why This Research Matters

This study provides neurobiological evidence for cannabis tolerance at remarkably low exposure levels. Even about 25 lifetime joints created measurable differences in how the brain responded to THC. This has implications for understanding why first-time or rare cannabis users may have more dramatic reactions, including psychotic symptoms.

The Bigger Picture

The finding that even modest cannabis exposure creates tolerance-like changes challenges the binary view of cannabis users versus non-users. The neurobiological adaptations from relatively few exposures suggest that the brain begins adjusting to cannabinoid signaling quickly, with implications for both safety (first-time users are most vulnerable) and research (comparing "users" to "non-users" may miss important gradients).

What This Study Doesn't Tell Us

The sample was small (24 participants) and exclusively male. The definition of "modest" use (about 25 joints) is arbitrary. The study cannot determine whether the blunted response in modest users represents true tolerance or selection bias (people less sensitive to THC may use more). Cross-sectional comparison of groups with different exposure histories limits causal inference.

Questions This Raises

  • ?At what threshold of cannabis exposure does tolerance develop?
  • ?Are the residual brain changes in modest users functionally significant in daily life?
  • ?Does the heightened vulnerability of never-users explain why some first-time cannabis users have psychotic reactions?

Trust & Context

Key Stat:
Never-users experienced significantly more THC-induced psychotic symptoms than modest prior users
Evidence Grade:
This is a well-designed randomized crossover study with neuroimaging, though limited by small sample size.
Study Age:
Published in 2018. Research on cannabis tolerance mechanisms continues.
Original Title:
Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing.
Published In:
Experimental and clinical psychopharmacology, 26(6), 582-598 (2018)
Database ID:
RTHC-01625

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled TrialGold standard for testing treatments
This study
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal Study

Participants are randomly assigned to treatment or placebo groups to test cause and effect.

What do these levels mean? →

Frequently Asked Questions

Why do first-time cannabis users sometimes have bad reactions?

This study found that people who had never used cannabis were significantly more affected by THC, experiencing more psychotic symptoms and cognitive impairment than those with even modest prior exposure. The brain appears to adapt to cannabinoid signaling after relatively few exposures.

Does using cannabis a few times change your brain?

Yes, according to this study. Even about 25 lifetime cannabis uses created measurable differences in brain function. Modest prior users processed attention and emotion differently from never-users, even under placebo conditions, suggesting lasting neuroadaptation.

Read More on RethinkTHC

Cite This Study

RTHC-01625·https://rethinkthc.com/research/RTHC-01625

APA

Colizzi, Marco; McGuire, Philip; Giampietro, Vincent; Williams, Steve; Brammer, Mick; Bhattacharyya, Sagnik. (2018). Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing.. Experimental and clinical psychopharmacology, 26(6), 582-598. https://doi.org/10.1037/pha0000221

MLA

Colizzi, Marco, et al. "Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing.." Experimental and clinical psychopharmacology, 2018. https://doi.org/10.1037/pha0000221

RethinkTHC

RethinkTHC Research Database. "Previous cannabis exposure modulates the acute effects of de..." RTHC-01625. Retrieved from https://rethinkthc.com/research/colizzi-2018-previous-cannabis-exposure-modulates

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.